Juan Andres

Chief Operating Officer

As Chief Operating Officer, Juan Andres works across Moderna to drive focus, prioritization and execution as the company continues to scale and diversify its business.

Mr. Andres previously spent nearly six years at Moderna, joining the company in 2017 and serving as Chief Technical Operations and Quality Officer from 2018 through 2022. During this time, he led the build-out and scale-up of Moderna’s manufacturing capabilities, including the expansion of its global manufacturing network to support production and supply of the company’s COVID-19 vaccine. He later served as President, Strategic Partnerships and Enterprise Expansion, working to establish focus on INT before retiring from Moderna in 2023.

Prior to joining Moderna, Mr. Andres spent 12 years at Novartis in leadership roles spanning technical operations, manufacturing and supply, quality, and technical research and development. Earlier in his career, he spent 18 years at Eli Lilly and Company in manufacturing, production and quality leadership roles.

Mr. Andres serves as an independent member of the Board of Directors of Lonza Group. He is also a member of the U.S. National Academy of Engineering.

Mr. Andres holds a Master of Pharmacy from the University of Alcalá de Henares in Spain and completed the Accelerated Development Programme at London Business School.